These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8551875)

  • 1. Acellular pertussis vaccines: new vaccines for an old disease.
    Poland GA
    Lancet; 1996 Jan; 347(8996):209-10. PubMed ID: 8551875
    [No Abstract]   [Full Text] [Related]  

  • 2. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 4. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acellular pertussis vaccine trials: an interpretation.
    Plotkin SA; Cadoz M
    Pediatr Infect Dis J; 1997 May; 16(5):508-17; discussion 517-9. PubMed ID: 9154547
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
    Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD
    Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
    Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF
    Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of acellular pertussis vaccine in Sweden. An attempt to solve the problem of pertussis vaccination.
    Olin P
    Ann Sclavo Collana Monogr; 1986; 3(1-2):165-72. PubMed ID: 2892504
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to make sense of pertussis immunogenicity data.
    Olin P; Hallander HO; Gustafsson L; Reizenstein E; Storsaeter J
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S288-91. PubMed ID: 11709761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-cell and acellular pertussis vaccines.
    Wintermeyer SM; Nahata MC; Kyllonen KS
    Ann Pharmacother; 1994; 28(7-8):925-39. PubMed ID: 7949515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids.
    Englund JA; Anderson EL; Reed GF; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Rennels MB; Deforest A; Meade BD
    Pediatrics; 1995 Sep; 96(3 Pt 2):580-4. PubMed ID: 7659480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
    Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations.
    Vidor E; Plotkin SA
    Hum Vaccin; 2008; 4(5):328-40. PubMed ID: 18398308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.
    Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.